Organon vs Viatris
OGN and VTRS side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How OGN and VTRS compare
Viatris is the larger company, worth 6.0 times as much as Organon ($21.9B against $3.6B).
Viatris grew revenue faster over the last twelve months (4.4% versus −3.2% for Organon).
Both pay dividends: Organon yields 0.58% and Viatris 2.5%.
Organon scores higher on the StockData Score (8 against 6 for Viatris), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | OGN | VTRS |
|---|---|---|
| Size and price | ||
| Market cap | $3.6B | $21.9B |
| Share price | $13.84 | $19.04 |
| Change, 1 year | 118% | 85.3% |
| Change, 5 years | −61.9% | 38.6% |
| Beta (5Y) | 0.83 | 0.87 |
| Employees | 10K | 30K |
| StockData Score | ||
| Total score | 8 (better) | 6 |
| Valuation score | 2 | 2 |
| Growth score | 0 | 1 (better) |
| Performance score | 2 (better) | 0 |
| Health score | 1 | 1 |
| Dividend score | 3 (better) | 2 |
| Valuation | ||
| P/E | 18.0× | – |
| P/S | 0.6× (better) | 1.5× |
| P/B | 3.0× | – |
| EV/EBITDA | – | 12.6× |
| P/FCF | 5.4× (better) | 11.2× |
| FCF yield | 18.6% (better) | 8.9% |
| Fair value | $14.66 | $20.87 |
| Margin of safety | 5.6% | 8.8% (better) |
| Growth | ||
| Revenue growth (TTM) | −3.2% | 4.4% (better) |
| Revenue growth, 5Y average | −0.99% | 3.7% (better) |
| Net income growth (TTM) | −57.5% | – |
| EPS growth (TTM) | −59.9% | – |
| EPS growth, 5Y average | −39.0% | – |
| Profitability | ||
| Gross margin | 53.1% (better) | 34.8% |
| Operating margin | – | −0.59% |
| Net margin | 3.5% | – |
| FCF margin | 11.1% | 13.3% (better) |
| Return on equity | 20.3% | – |
| Financial health | ||
| Debt / equity | 7.17 | – |
| Net debt / EBITDA | – | 4.59 |
| Interest coverage | – | −0.2× |
| Current ratio | 2.02 (better) | 1.58 |
| Altman Z-score | 1.03 | 1.16 (better) |
| Piotroski F-score | 5 | – |
| Dividends and buybacks | ||
| Dividend yield | 0.58% | 2.5% (better) |
| Payout ratio | 9.4% | – |
| Years of dividend growth | 0 | 0 |
| Buyback yield | – | 1.4% |
| Shareholder yield | 0.58% | 3.9% (better) |
| Ownership | ||
| Held by institutions | 83.3% | 91.5% |
| Held by insiders | 0.49% | 0.36% |
| Insider net buying, 12 months | $301K (better) | −$1.1M |
| Superinvestors holding | – | 3 |
| Short interest, % of float | 7.3% | 3.7% |
Go deeper
- OGN stock overview
- OGN income statement
- OGN valuation and score
- VTRS stock overview
- VTRS income statement
- VTRS valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.